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Abstract 
 
 
 
This work focuses on the characterization of nanoparticle (NP) delivery in 
microcirculation. In microvasculature network, the vessel size is comparable to that of 
red blood cells (RBCs) and the existence of blood cells largely influences the dispersion 
and binding distribution of NPs. The geometry of the microvasculature leads to non-
uniform particle distribution and effects on the particle binding characteristics. We 
perform an in vitro study in a mimetic microfluidic chip, on the various factors that 
influence NP distribution and delivery such as vessel geometry, blood cells, particle size, 
and shear rates.  RBCs are found to enhance the binding of NPs at all shear rates and for 
microparticles at higher shear rates. RBCs also interfere with the binding of 
microparticles at low shear rates. The NP binding density is around ten times higher 
when NPs flow along with 40% RBCs compared to the pure particle case. RBCs bring in 
an enhancement of two hundred fold in binding density for 3 µm particle at high shear 
rates when compared to the pure particle case.  Higher particle binding density is also 
observed at bifurcation region of the microvasculature geometry.  
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Chapter 1: INTRODUCTION 
 
1.1 Background  
1.1.1 Microfluidics 
Microfluidics is the characterization and manipulation of fluids on the nanoliter or 
picoliter scale in channels with dimensions of tens to hundreds of micrometres. The main 
advantages of applying microfluidic platforms are: use of very small quantities of 
samples and reagents, processing separations and detections with high resolution and 
sensitivity; low cost; short processing time and scaling down of size [1]. Most of the 
research in microfluidic systems are carried out on poly(dimethylsiloxane) (PDMS) [2-3]. 
PDMS is an optically transparent, soft elastomer. Ease of fabrication based on soft 
lithography allows new concepts to be easily incorporated in PDMS platform and tested 
[4]. This has made it a key material for exploratory research and research engineering at 
the early stages of development.  
Currently, microfluidics platform has been applied in wide range of fields. In 
protein crystallization studies, microfluidic platform works as a sensor to screen 
conditions such as pH, ionic strength and composition, concentration etc. [5-6]. Other 
laboratory applications include high-throughput screening in drug development[7-8] mass 
spectroscopy coupled separations [9], bioanalyses[10], single cell or molecule 
examination and manipulation[11-14]. Microfluidic platforms has been used in the 
manipulation of multiphase flows, enabling the generation and manipulation of 
monodisperse bubbles[15-16] or droplets[17-18]. This feature has been applied in the 
production of polymer particles, emulsions and foams [19]. The microscale physics and 
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phenomena of microfluidic devices has been used to create systems that provide 
functionality useful to the life sciences. Macroscale systems has been brought down to 
the microfluidic "lab-on-a-chip" platform[20], an incorporation of multiple aspects of 
modern biology or chemistry labs on a single microchip. 
 
1.1.2 Microfluidics in biology 
Biological systems are complex which makes accurate and precise 
experimentation to be a cumbersome task. Most biological experimentation focuses on 
highly detailed patterns in the micron level, which lacks the throughput necessary to 
reconstruct the entire biological system. High-throughput testing platform often lacks the 
fidelity and detail necessary to fully comprehend the micron scale mechanisms. Recent 
advances in the bio and nano technologies have led to the development of novel, 
biological microsystem platforms for application and analysis in the field of life science. 
These microsystems provide an opportunity to comprehend studies in detail and high-
throughput analysis is possible by massively arraying devices on a chip [21]. These new 
platforms have revolutionized the way we do science and have led to the development of 
a number of ultrasensitive bio-analytical devices.  
Microfluidic lab-on-a-chip devices have found application in a number of diverse 
areas such as pollution monitoring, clinical diagnostics, drug discovery and biohazard 
detection. High-resolution and localized application of experimental conditions in 
biomimetic physiological conditions, practically promotes the implementation of the 
system in all possible directions. 
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Standard laboratory analyses such as, sample purification, labeling, detection and 
separation have been performed automatically in microfluidic platform as the sample is 
moved via microchannels to different regions of a chip. On-chip cell detection and 
handling techniques like cell culture devices, microfabricated flow cytometers, cell 
sorting devices etc. have also been possible on microfluidic platforms. Microfabricated 
cell culture devices have made possible the analysis of drug effects, osmotic balance, 
cytogenic and immunologic responses and metabolism in an in vitro set up [7]. Recently 
even culture of stem cells have been performed on these platforms [22]. Optical tweezer 
based capture of beads, cells and deoxy ribo nucleic acid (DNA) has been performed on 
microfluidic devices [23]. Devices capable of performing high-throughput analysis of the 
electrical properties of single cells and other organisms have also been developed [24]. 
High-speed analysis and sorting of individual cells and polymer beads based on their 
optical properties are also available on the microfluidic platform [25-26].  
On-chip separation techniques for subcellular components such as proteins and 
DNA have found wide application in the area of micro total analysis systems [27-29]. 
Different variants of the standard enzyme-linked immunosorbent assay have been 
demonstrated on microfluidic chip. On-chip examples include the detection of HIV-1 
from infected and non-infected patients[30], the detection of cytokine tumor necrosis 
factor α with picomolar sensitivity[31], the integration of standard immunostrip into 
microflow channels for the detection of cardiac troponin I[32] and the use of 
microfabricated filters for bead-based detection of viruses [33]. 
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1.1.3 Microfluidics in drug delivery 
The ability of microfluidic technology to miniaturize assays and increase 
experimental throughput have generated significant interest in the drug discovery and 
development domain. It has been applied in different stages of the process, including 
target selection, lead identification, preclinical tests, clinical trials, chemical synthesis, 
formulations studies and product management [34-35]. Much of drug discovery and 
applications are based on the selective binding of low molecular weight molecules to 
bioactive macromolecules [36]. Typically, these ligand-binding studies are performed by 
exposing the target to various concentrations of a compound. Microfluidic devices have 
been used for ligand-binding studies to minimize interaction times, improve sensitivity 
and increase throughput.  
 
1.1.4 Proposed work in drug delivery 
In this thesis an evaluation on the distribution and adhesion of drug carrier 
particles in an in vitro biomimetic microfluidic platform is performed. The distribution of 
particles in the nano and micron range is studied under different physiologically relevant 
shear rates in channels that mimic microvasculature. The channels are coated with 
biomolecules that are overexpressed by the endothelial cell layer of diseased 
microvasculature. In this way, the channels of the microfluidic device exhibit conditions 
similar to in vivo. Particles mimicking drug carriers are coated with ligands having 
affinity to these biomolecule coated in the channels and are flown through them. 
One of the primary modes of applying drug particles is through blood vessels. 
Therefore, RBCs and the blood vessel geometry can influence the particle transport 
 6 
 
characteristics. Our work also studies the effect of RBCs on particle distribution and 
binding dynamics. The microchannels also incorporate straight and bifurcating features 
present in typical microvasculature network. 
 
1.2 Characterization of NP delivery in microcirculation: the influence of 
blood cells and vascular geometry 
 
 
1.2.1 Targeted nano drug carriers in microcirculation 
Various techniques in NP targeted drug delivery have been developed in recent 
years  to reduce side effects, toxicity, and lower drug dosage [37]. The use of NPs in drug 
delivery help in targeted delivery and release of drugs at disease region, serving the dual 
role of diagnosis and therapy [38]. The drug uptake efficacy of NP based drug carriers is 
higher compared to the larger particle carriers which are easily cleared off by the human 
mononuclear phagocyte system. NPs also have larger surface to volume ratio[39], which 
helps attachment of  multiple functional groups and thereby enhance targeting. Nano drug 
based delivery systems has great potential to achieve efficient targeting of cells and 
molecules in inflammation and cancer conditions [40]. 
 
1.2.2 Current challenges in the study of drug delivery and distribution 
Recent theoretical modeling works demonstrate a decrease in NP adhesion 
probability with an increase in local blood flow rate [41]. Due to bioethical regulations 
and complex physiological conditions, it is very challenging to quantify the NP delivery 
process in vivo. Most of the current studies are carried out in vitro by flowing NP buffer 
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solutions in flow chambers or channels [42-43]. However, the result from these studies 
are applicable to large blood vessels but not to microvasculature. Microvasculature refers 
to part of the circulatory system consisting of capillaries, arterioles, and venules [44]. 
Microvasculature parameters such as vascular geometry, target receptors expression level 
and flow shear rate, must be considered while performing these studies in vitro. Study on 
specific receptor mediated binding of nano drug carriers under various physiologically 
relevant conditions help in understanding parameters that allow enhanced targeted 
delivery and also determine the actual bioavailability of drugs. This work also addresses 
the current challenge of quantifying NP binding density at specific vascular locations, 
which is critical for clinical drug dosage control.  
 
1.2.3 Distribution of nano drug carriers under the influence of RBC 
Relevant works on characterization of NP delivery assumes NPs in a buffer 
suspension without considering RBCs [42, 45]. Blood is a complex bio-fluid consisting 
of RBCs, monocytes, platelets, proteins etc. Blood flow in microvasculature is a two-
phase phenomenon as the vessel diameter becomes comparable to the size of RBCs. In 
vitro studies on RBC mediated particle delivery has to consider various in vivo 
microvasculature parameters, such as Fåhraeus–Lindqvist effect [46], Segre–Silberberg 
effect [47-48], cell-free-layer (CFL) formation [49-51], vessel bifurcations [52] and blunt 
velocity profile [53-56].  
When flowing along with RBCs, their shape, size and concentration can induce 
movements not available in homogenous fluids [57-59]. RBCs under shear flow can form 
small regions of convection under its rotating and colliding movement. This can give way 
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to apparent raise in diffusion coefficient for particles in flow along with RBCs.  The 
targeted binding of nano drug carriers to diseased cells requires the NPs to marginate 
toward the vascular wall. RBCs tend to flow in the core region of blood stream thereby 
dispersing out the NPs to the nearby wall region. This phenomenon largely influences NP 
distribution and binding dynamics. In this work, we will consider the influence of RBCs 
on NP distribution and binding under different vascular shear rates and geometries. 
 
1.2.4 Influence of vessel geometry in nano drug carrier distribution  
Vascular geometry is another factor that has not been well studied in NP delivery 
process. Blood circulatory system consists of large blood vessels like the arteries and 
veins (~15-0.5 mm), smaller vessels like the arterioles, venules (100-500 µm) and 
capillaries (~10 µm). The distribution of drug particles in real vascular network having 
hierarchical geometry will depend on local shear rate, flow velocity, pressure and volume 
[60]. Our study considers the distribution of nano and micron sized particles in a 
branching channel that mimics the geometry and flow conditions of a complex 
vasculature network. Also a comparison of particle binding density between the 
bifurcating channel and the straight channel is performed to examine the effect of non-
uniform distribution of particles at vessel bifurcations with and without RBCs. 
The specificity of targeting is brought about by applying ligand-receptor 
chemistry in our microfluidic platform. The biomimetic chip is coated with intercellular 
adhesion molecule 1 (ICAM-1) protein, a cell-surface glycoprotein member of the Ig 
super-family. Under inflammatory conditions, interaction between endothelial cells and 
blood constituents occur by the up-regulation of intercellular adhesion molecules such as 
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ICAM-1 on the surface of endothelial cells and leukocyte [61-62]. This mediates the 
targeted migration of leukocytes into specific areas of inflammation [63]. Various ICAM-
1 based therapeutic agents for cancer immunotherapy and other modes of treatment are 
used nowadays [64-65]. ICAM-1 is also not known to produce any conformational 
change under shear like von Willebrand Factor that might affect the binding behavior of 
particles. Anti-ICAM-1 coated 100 nm particles are used as a model system to study the 
influence of RBCs and vascular geometry on NP delivery. A comparative study is 
performed with 3 µm particles and to study how particle size influences the binding 
characteristic. 
In the following sections, methods applied to modify the microfluidic platform are 
discussed along with various testing conditions. The results and discussion section 
addresses the binding characteristics of 100 nm and 3 µm particles. The influence of 
particle size in binding is analyzed next followed by the influence of RBCs. Finally, the 
conclusion and future work are presented. 
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Chapter 2: Experimental methods 
 
 
2.1 Materials 
Human ICAM-1/CD54 FITC MAb (Clone BBIG-I1) Mouse IgG1, ICAM-
1/human IgG1 Fc chimera (R&D Systems, Minneapolis, MN), protein G (Biovision, 
Milpitas, CA), fluorescent red latex 100 nm particles, bovine serum albumin (BSA), 3-
aminopropyltrimethoxysilane (Sigma Aldrich, St Louis, MO), 3 µm particles 
(Spherotech, Lake Forest, IL), Polydimethylsiloxane (Dow Corning, Midland MI), single 
donor human whole blood (Innovative Research), tygon tubing, syringe, needles.  
 
2.2 Microfabrication 
The required microfluidic design is photo-lithographically patterned on a silicon 
wafer using SU-8 2050 photoresist. Microfluidic devices are fabricated using Sylgard 184 
PDMS. PDMS base is mixed with its cure at 1:10 (v/v) ratio following the basic 
techniques in soft lithography[66]. The PDMS mixture is poured on the silicon wafer, 
which acts as the master template. The hard PDMS layer is peeled out after baking and 
the features are inspected. The microfluidic device is made by binding the PDMS pattern 
on a clean glass slide after exposing them to oxygen (O2) plasma. The flow channels are 
100 microns (µm) wide and 40 µm in height. Both straight and bifurcating features are 
included in the design. 
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2.3 ICAM-1 modified PDMS Substrate  
After binding with glass, the PDMS devices were silanized with 3-
aminopropyltrimethoxysilane to improve protein adsorption. Unbound silane molecules 
were removed by washing the device with an adsorption buffer (0.1M NaHCO3, pH 9.2). 
Then the devices were incubated for 2 hrs at room temperature with saturating 
concentration of protein G in adsorption buffer (100 µg/ml). ICAM-1 Fc chimera protein 
solution in PBS (100 nM) was introduced after washing the substrates three times with 
PBS to remove any excess protein G. The devices were incubated with ICAM-1 for 1 hr 
at room temperature [42]. The microfluidic chips were purged with 1% BSA containing 
0.05% Tween20 one hour prior to testing. Devices were flushed with PBS to remove any 
unbound BSA before testing. 
 
 
 
B 
Fig. 1: (A) Auto CAD design of microchannel geometry, Inset illustrates the fabricated 
microfluidic chip during RBC-particle mixer testing; (B) The flow test set-up. 
 
A 
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2.4 Anti-ICAM-1 coated micro/nano particles 
Anti-ICAM-1 protein is passively adsorbed on the 3 µm and 100 nm fluorescent 
polystyrene particles as previously described [67-69]. The particles were incubated 
overnight in anti-ICAM-1 solution (100 mg/ml). The antibody and particles were mixed 
in a suitable buffer and placed in an orbital shaker at room temperature.  The particles 
were used immediately after three washes to ensure the complete removal of free or 
unbound proteins. The Fc (Fragment, crystallizable) portion of the ICAM-1 antibody is 
more hydrophobic and gets adsorbed on the polystyrene surface than the antigen binding 
region, providing a biologically active orientation. BSA coated particles were used as 
negative control. Flow cytometry based analysis was performed on the particles to 
evaluate protein coating. 
 
2.5 Biodistribution test 
Anti ICAM-1 coated particles were flown through ICAM-1 modified microfluidic 
devices at different shear rates between 8 to 100 s-1. This corresponds to physiologically 
relevant values observed in the microvessels [70-74]. The flux rate is kept constant at 
Fig. 2: Illustration of the steps involved in anti-ICAM-1 coating of PDMS surface. 
Hydrophobic 
PDMS surface 
O
2
 Plasma 
treatment 
Hydrophilic 
PDMS surface 
3-Amino 
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1012 and 5*109 for 100 nm and 3 µm particle case respectively. Fluid flow was brought 
about using a programmable syringe pump (Harvard Apparatus). The fluid flow rate 
controls the volumetric flow rate which is proportional to the wall shear rate. The wall 
shear rate γ w was derived from the volumetric flow rate  using the following relation 
[42]: 
γ w= 6Q/HW 
'H' is the height and 'W' is the width of the microfluidic device.  
Each flow test case was run for 10 min and the microfluidic chips were washed 
with PBS for clearing any unbound particles in the 100 nm case. The biodistribution of 
NPs were analyzed on a high resolution laser confocal fluorescence microscope 
(FV1000-IX81, Olympus). Washing out unbound 3 µm particles posed higher probability 
of detachment due to external influences. Here the flow set up was assembled on the 
stage of an inverted fluorescence microscope and after 10 min of flow, the imaging was 
performed keeping the exposure time low. Only the bonded 3 µm fluorescent particles 
were captured by the cooled CCD camera device, while the free flowing once appeared 
blurred.   
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Chapter: 3 Results and Discussion 
 
 
The microfluidic device is designed to mimic the geometry of a typical 
microvasculature. The design contains both straight and branching channels. In our study, 
the tests are carried out on a range of wall shear rates between 8 to 100 s-1. The particle 
flux is kept constant based on the shear rate to make sure the total number of particles 
flown through each device is same for all the cases. This represents a constant drug 
dosage in clinical setup.  
Three testing conditions are carried out in this work: particles in pure buffer, 
particle mixed with 40% RBC (hematocrit percentage) and particle mixed with diluted 
RBC to reach the same effective concentration as pure particle case. The effective 
concentration case has the same available free space for particles as compared with pure 
particle case even though RBCs are added to the suspension. The latter two cases help in 
studying the influence of RBCs on particle diffusion process and binding dynamics. 
RBCs have a biconcave shape of ~8 µm diameter and ~2 µm thickness, and is highly 
deformable [51, 75].  In microvessels the flexible RBCs migrate radially towards the 
center region based on different hemorheology factors such as shear rate, viscosity, 
hematocrit concentration, RBC aggregation and deformability. This result in a RBC 
concentrated core region and a cell-free plasma layer near the vascular wall called cell 
free layer (CFL) [49, 75-76]. 
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Fig. 3: (A) Fluorescent image of 100 nm particle flow at 100 s-1 shear rate in a 20 µm 
channel; (B) Fluorescent intensity across channel width under pure 100 nm particle 
flow at 100 s-1 shear rate; (C) Fluorescent image of 100 nm particle flow with 40% 
RBCs at 100 s-1 shear rate in a 20 µm channel; (D) Fluorescent intensity across channel 
width for 100 nm particle flow with 40% RBC at 100 s-1 shear rate. 
C A 
B D 
3.1 NP distribution across channel 
To find out the distribution of NPs in a microchannel during flow, fluorescent 100 
nm particles were flown through a 20 µm channel at a shear rate of 100 s-1. Fluorescence 
intensity based distribution of NPs in the channel was analyzed. Fig. 3A and 3C shows 
100 nm particle distributions at pure particle and RBC 40% case respectively. The 
fluorescence intensity distribution in pure particle case (Fig. 3B) shows uniform particle 
distribution along the channel width.  
The RBC 40% case (Fig. 3D) shows an interesting non-uniform distribution of 
NPs in blood flow, with peaks coincident with the CFL. A high intensity of 0.08 is 
observed near to the wall region and in the core region the intensity decreases to 0.01. 
Such non-uniform distribution indicates that RBCs tend to migrate towards the core 
region during flow which leads to the margination of NPs to the near wall CFL region, 
leading to higher fluorescence intensity.  Such high NP concentration near the CFL 
results in higher binding rate, which is presented in the following sections. 
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3.2 100 nm particle binding distribution 
The 100 nm particles show an increase in particle binding density at decreased 
shear rates. Fig 4 shows confocal scanning fluorescence image of particle binding 
distribution for the 40 s-1 and the 8 s-1 shear rates. The particle binding density for RBC 
40% case is higher compared to the pure particle case (Fig. 4C compared to 4A and Fig. 
4F compared to 4D). The effective concentration case also shows enhanced binding 
compared to the pure particle case (Fig. 4B compared to Fig. 4A and Fig. 4E compared to 
Fig. 4D). 
To quantify and characterize the influence of RBC and channel geometry on NP 
binding, we measure the binding density by counting individual bonded particles through 
image processing. The particle binding density is calculated based on the number of 
particles bonded per unit area (#/µm2). Fig. 5 compares the particle binding density for 
straight and branched channel cases. Both show a decrease in binding density of NPs 
with increased shear rates. The binding of receptor coated particles flowing in ligand 
modified surface is governed by the shear rate of flow. At high shear rates, there is less 
probability for binding to take place leading to a fall in particle binding density. Shear 
rate determines the critical time available for adhesive receptor/ligand organization and 
thereby cross-linking leading towards binding [77]. The mean contact time for bond 
formation between a receptor/ligand pair decreases with increase in shear rate, thereby 
decreasing the efficiency of bond formation. At lower shear rates the NPs have longer 
time period to process multivalent bond formation process under the complex dynamic 
flow condition. This leads to higher particle binding density at lower shear rates and 
decrease in particle binding density with an increase in shear rate [68].  
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The RBC 40% case exhibits around 10 times higher binding density compared to 
that of pure NPs flow. This enhanced binding is induced by the axial-migration and 
tumbling motion of RBCs undergoing deformation, which leads to the exclusion of NPs 
from the center region to the CFL [51, 75]. This increase in NP density near the wall 
region leads to more frequent interaction between the anti-ICAM-1 coated NPs and the 
Fig. 4: Confocal fluorescence image showing distribution of anti-ICAM-1 coated 100 
nm particles in a branched channel (top) and a straight channel (bottom) under different 
flow conditions and shear rates; (A) 40 s-1, pure particle case; (B) 40 s-1, effective 
concentration case; (C) 40 s-1, RBC 40% case; (D) 8 s-1, pure particle case; (E) 8 s-1, 
effective concentration case; (F) 8 s-1, RBC 40% case. (Scale bar: 100 µm) 
B A 
E D F 
C 
 18 
 
ICAM-1 coated wall surface, thus higher probability for binding. The particle binding 
density increases around 2.5 times in the effective concentration case compared to the 
pure particle flow. This indicates that the enhanced NP binding in the RBC 40% case is 
not just because of volume exclusion, but a combined effect along with the migration of 
particles towards the near wall CFL region.  
 
3.3 3 µm particle binding distribution 
To explore whether the observed NP binding pattern under different flow 
condition apply to microparticles, tests were carried out on 3 µm particles which is 
similar to the size of platelets.  
Confocal fluorescence images of anti ICAM-1 coated 3 µm particle distribution 
on ICAM-1 modified straight and branched channels are shown in Fig 6. Particle 
distribution at 8 s-1 shear rate for pure particle case and RBC 40% case are shown in Fig 
6A and Fig. 6B respectively. Similarly, Fig. 6C and Fig. 6D show particle binding 
distribution for pure particle case and RBC 40 % case at 100 s-1 shear rate respectively 
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Fig. 5: Particle binding density (#/µm2) at shear rates between 8-100 s-1 under pure 
particle flow (red line), effective concentration flow (black dashed line) and RBC (40%) 
flow (blue dotted line) for 100 nm particles in; (A) straight channel; (B) branched 
channel 
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Fig. 6: Confocal fluorescence image showing distribution of anti-ICAM-1 coated 3 µm 
particles in branched channel (top) and straight channel (bottom) under different flow 
conditions and shear rates; (A) 8 s-1, Pure particle case; (B) 8 s-1, RBC 40% case; (C) 100 
s-1, Pure particle case; (D) 100 s-1, RBC 40% case. (Scale bar: 100 µm)  
 
In Fig. 7, the 3 µm particle binding densities in a straight and a branched channel 
are compared. To compare with the 100 nm case, the binding density of 3 µm particles 
have been normalized to reach the same scale as 100 nm particles as the particle flux used 
were different. The pure particle case shows decrease in particle binding density with 
increase in shear rate for both straight and branched channel cases. Similar results have 
been observed in other studies [78] and in our 100 nm particle binding study (Fig. 5). 
However, for the RBC 40% case, an increase in particle binding density is 
observed with increased shear rate. This is contradictory to what is observed in the NP 
case. At lower shear rates, RBCs interfere with the attachment or promotes the 
detachment of attached microparticles. This might be induced by the brushing/colliding 
of RBCs against the bonded microparticles as they flow much closer to the vessel wall at 
low shear rates. With a decrease in shear rate, the CFL thickness reduces because the 
RBCs have a reduced tendency to migrate towards the center and the flow also has a 
blunt velocity profile [76, 79-80] [49]. This would allow these RBCs to brush against the 
B C D A 
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attached microparticles and thus detach them from the ICAM-1 coated surface. Such 
phenomenon is not observed under high shear flow conditions [68]. At higher shear rate, 
a wider CFL reduces the interaction between the flowing RBCs and bonded 
microparticles and explains the increase in microparticle binding. Similar enhanced 
concentration near the wall region and binding at shear rates above 50s-1 is observed for 
platelets [81-84].  
 
Compared to the pure particle case, almost an increase of 200 fold is observed in 
binding density for the RBC 40% flow case at high shear rates. Here, a size based 
exclusion effect increases the margination of 3 µm particles to the near wall CFL region 
from the RBC concentrated core region as seen in previous works[85-86]. This 
effectively increases the concentration of 3 µm particles in the near wall CFL region. 
Thus the particles are confined in between the channel walls and the RBC concentrated 
core region and being in this transport limited region, the interaction between the RBCs 
and targeted particles increases the collision between the anti-ICAM-1 coated particles 
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Fig. 7: Particle binding density (#/µm2) at shear rates between 8-100 s-1 under pure 
particle flow (red line) and RBC (40%) flow (blue dotted line) for 3 µm particles in (A) 
straight channel and in (B) branched channel  
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with the ICAM-1 coated PDMS surface. This phenomenon have been observed and 
explained in other works [86-87]. This excess RBC generated force on the particles helps 
them in overcoming the disruptive forces generated by increased shear rate and thus helps 
in binding. This increases the particle binding density for 3 µm particles at high shear 
rates. 
 Comparatively, only a smaller percentage of 100 nm particles marginate to the 
near wall region [88] while most of them still tend to flow along with RBCs in the core 
region because of their smaller size. This along with their smaller size compared to the 
CFL (2-20 µm [89])  reduces their interaction with the RBC core and thereby produces 
lesser increase in particle binding density compared to the 3 µm particle case. 
 A study on diffusivity of platelets on channels comparable to microvasculature 
found RBCs increase the range of diffusivity 50 to 250 times depending on hematocrit 
concentration and shear rate applied [90]. Our results follow similar trend with 
microparticles being of size comparable to that of platelets.  
 
3.4 Mathematical modeling of particle binding  
The particle binding density data for 100 nm and 3 µm particles based on shear 
rate shows a non linear drop over shear rate. This is observed for all the three test cases in 
the 100 nm particle flow case and pure particle flow case for the 3 µm particles. The only 
exception is the 40% RBC, 3 µm particles case as its particle binding characteristics are 
heavily influenced by RBCs. In order to understand the effect of shear rate in particle 
binding density, a mathematical model is introduced. 
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An analytical model is proposed for the relationship between shear rate and 
particle binding density. The number of particles in an annular region within the distance 
reachable by diffusion can be estimated as: 
	
  #   	 

 

   
 
Where A stands for the binding area, d stands for the average distance induced by 
Brownian motion, c stands for the concentration and V stands for the volume within 
which particles could be bound. 	
 stands for particle binding density. Here, the 
distance induced by Brownian motion could be calculated as following: 
  √2"# 
 
Where D stands for diffusion coefficient of particles. 
 
The time t could be calculated as.  
#  $%  &
$
γ ' 
So substitution yields: 
  ()2"$*γ +
,/-
 
In consideration of the concentration c, based on the particle number 
conservation, we have:.%/#  0.# 1   02/  0345
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Where 0A  is the crossing area of the channel, %/ is the average velocity, t is the 
flowing time and φ is the particle flux which is constant in our experimental case. Q is 
the flow rate which could be expressed as: γ w= 6Q/HW 
Where H is the height of the channel and w is the width of channel. So 
substitution yields:  6034789:   607:  
Hence, we could attain the relationship between particle binding density and shear 
rate as:  
	
   60;γ  . &2"$γ '
,/-   6. )2"$*,/-0  ;γ 4/3  
 
Following this relationship we analytically attain the relationship between particle 
binding density at different shear rates, as shown in Fig. 8. 
 
 
Fig. 8: Particle binding density in analytical study at shear rates between 8-100 s-1 (black 
curve). Blue star represent particle binding density of 100 nm particles at pure particle 
flow in straight channel and red circles represent particle binding density of 3 µm 
particles at pure particle flow in straight channel. 
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In Fig. 8, the black curve represents the particle binding density from the 
analytical solution. A significant fall in particle binding density is observed between 
shear rates of 8-16 s-1.
 
This validates the role played by shear rate in the erratic drop in 
particle binding density observed for the 100 nm (blue stars) and 3 µm (red circles) 
particles cases at lower shear rates in the experimental work. We compare the particle 
binding density found experimentally for 100 nm particles and 3 µm particles in the pure 
particle flow case in straight channel to the trend seen in analytical work. Both cases 
follow similar trend. In the experimental work, the flow cases with RBCs exhibit similar 
trend in binding, though RBCs tend to amplify the particle binding density. 
 
3.5 Influence of particle size on binding density 
Fig. 9 compares the binding density in straight and branched channels for 100 nm 
and 3 µm particles at shear rates between 8-100 s-1 for pure particle case. The 100 nm 
particles show higher particle binding density compared to the 3 µm ones and the binding 
density decreases with increased shear rate. The ratio of particle binding density between 
100 nm and 3 µm particles increases with shear rate (inset graph). About 9 fold higher 
particle binding density is observed for100 nm particles compared to 3 µm particles at 
100 s-1 shear rate. This decrease in particle binding with an increase in particle size is 
consistent with that reported in literature [91] especially at higher shear rates [92]. With 
an increase in shear rate, the disruptive force and torque acting on a 3 µm particle is 
larger compared to smaller 100 nm particles [93] . The binding of particles to a surface 
depends on the balancing of disruptive force from shear flow and adhesive force from the 
receptor ligand bonds. Particles of bigger size has reduced binding and in our study the 
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increase in shear rate reduces the binding of  3 µm particles. As explained before, the 100 
nm particles diffuse more to the wall region compared the 3 µm particles based on 
particle size. This also promotes better NP binding for pure particle case.  A slightly 
higher binding density is found for both 100 nm and 3 µm particles in branching channels 
compared to straight channels.  
 
3.6 Influence of RBC on binding density of particles with different sizes 
The influence of RBCs on particle binding varies according to particle size.  Fig. 
10 compares the particle binding density in straight and branched channels for 100nm 
 
Fig. 9: Comparison of particle binding density (#/µm2) in straight and branched channels 
for 100 nm particles and 3 µm particles at shear rates between 8-100 s-1 for pure particle 
case
. Inset graph shows ratio of 100 nm to 3 µm particle binding density at shear rates 
between 8-100 s-1 for pure particle, straight channel case.  
0
0.02
0.04
0.06
0.08
0.1
0.12
8/s Straight 8/s 
Branched
16/s 
Straight
16/s 
Branched
40/s 
Straight
40/s 
Branched
100/s 
Straight
100/s 
Branched
Pa
rt
ic
le
 
bi
n
di
n
g/
A
re
a 
(#/
u
m
2 )
Shear rate
100 nm particle
3 um particles
 
0
2
4
6
8
10
8/s 16/s 40/s 100/s
A 
 26 
 
and 3 µm particles between 8-100 s-1 shear rates for the RBC 40% case. As explained 
before, the particle binding density for 100 nm particles decrease with shear rate, while 
for the 3 µm particles the binding density increase with shear rate. The inset graph in Fig. 
10 compares the ratio of particle binding density in branched versus straight channels at 
different shear rates for both particle sizes. 
 
For the 3 µm particles, an increase in particle binding density is observed at the 
branching channels compared to the straight channels with increased shear rate (ratio 
increases from 1 to ~1.8). No significant difference in particle binding density between 
branched and straight channels was observed for the 3 µm particles in the pure particle 
case. There is also no significant difference in binding density for the 100 nm particles in 
Fig. 10: Comparison of particle binding density (#/µm2) in straight and branched 
channel for 100nm and 3 µm particles between 8-100 s-1 shear rates for RBC 40% case. 
Inset graph shows ratio of particle binding density in straight vs. branched channels for 
100 nm (blue diamond markers) and 3 µm (red square markers) particles at shear rates 
between 8-100 s-1 for RBC 40% case with trend lines. 
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branched versus straight channels as well (ratio close to 1). Similar trend was observed 
for the pure particle flow case for 100 nm particles (Fig. 9). When flowing along with the 
RBCs, a higher percentage of the 3 µm particles get excluded in to the CFL based on size 
[86], compared to their 100 nm counterparts. At higher shear rates the RBCs tend to 
concentrate in the core region of flow while pushing out the 3 µm particles of comparable 
size to the near wall CFL. This size based exclusion effect marginates more 3 µm 
particles and brings more of the anti-ICAM-1 coated particles in contact with the ICAM-
1 coated PDMS surface and produce almost two times higher binding density because of 
flow disturbances or alteration at the bifurcation [94-95].  
100 nm particles show lower binding density compared to the 3 µm particles at 
the 100 s-1 shear rate with RBCs (Fig. 10). As explained before, size exclusion factor and 
increased collision to RBCs allows higher percentage of 3 µm particles to come in 
contact with the wall surface and produce enhanced binding. Only a small percentage of 
100 nm particles marginates to the near wall region while most of them still tend to flow 
along with RBCs in the core region because of their smaller size or they flow within the 
CFL as explained before. With an increase in shear rate less number of 100 nm particles 
comes in contact with the wall surface and there is less probability for binding. These 
factors lead to decrease in particle binding density for 100 nm particles compared to 3 µm 
particles at higher shear rates when flowing with RBCs. The RBC 40% case produce 
higher binding density for 100 nm particles at low shear rates while the bigger 3 µm  
particles shows better binding density at higher shear rate. 
 
 
B 
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 Chapter: 4 Conclusions 
 
 
The binding density of anti-ICAM-1 coated particles of 100 nm and 3 µm size on 
ICAM-1 modified PDMS microfluidic devices is characterized in this work. The study 
employs various factors that influence particle distribution and binding such as RBCs, 
particle size, vessel geometry and shear rates.  
RBCs play a major role in binding and distribution pattern of both 100 nm and 3 
µm particles. Based on the test results, it is found that RBCs enhance particle binding. 
100 nm particles showed ~10 fold increase in binding at low shear rates when compared 
to the pure particle case. Similarly, 3 µm particles showed ~200 fold increase in binding 
at high shear rates compared to the pure particle flow case. With variation in flow shear 
rate the CFL thickness changes. This is induced by margination of particles to the near 
wall CFL, which is influenced by shear rate. Axial-migration/tumbling motion of RBCs 
excludes particles to the CFL, leading to a non-uniform particle distribution. Based on the 
size exclusion factor, higher percentage of 3 µm particles marginates towards the CFL 
compared to the 100 nm particles. Once in the CFL, RBC mediated collision of 3 µm 
particles to the wall surface also enhances the binding probability. Because of their 
smaller size, the effect of size exclusion factor is low on 100 nm particles.  
The 100 nm particles exhibit higher binding density compared to 3 µm particles at 
all shear rates for the pure particle case. The particle binding density decreases with an 
increase in shear rate. Based on the particle size the force acting on them varies with 
shear rate. The smaller 100 nm particles have much lower drag force acting on them 
compared to the 3 µm particles and therefore better probability for the ICAM-1  based 
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ligand-receptor binding to occur. Also the smaller 100 nm particles exhibit better 
diffusion to the wall region compared to the 3 µm particles. 
In terms of vessel geometry, 100 nm particles show slight increase in binding 
density at the branch channels compared to the straight channels for both pure particle 
and RBC 40% case. Similar pattern is shown by 3 µm particles for the pure particle case. 
For the RBC 40% case the 3 µm particle exhibit higher binding density at the branching 
section of the channel compared to the straight channels. This trend increases with shear 
rate and almost reaches 2 fold at 100 s-1 shear rate.  
These results help to determine the transport properties of drug carriers in the 
microvasculature. From this work we conclude that better drug delivery is attained in low 
shear rate sections of microvasculature by NP sized carriers. Whereas for achieving better 
drug delivery in microvasculature sections of high shear rate, microparticles of platelet 
size range would be a more suitable candidate. On choosing the right size range, better 
bioavailability and enhanced targeted binding of the drugs is achieved. This will provide 
higher efficacy and minimal drug dosage.  
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Chapter: 5 Future Work 
 
 
The current work is part of a big project to develop customized biomimetic 
microfluidic experimental platform that mimics specific microvasculature conditions 
based on disease state and physiological spot of origin. The project is to be taken to the 
next level by engineering the microfluidic channels to mimic vascular morphology by 
coating them with endothelial cells. The endothelial cell layer is to mimic disease 
condition by introducing required cytokines. This allows the expression of the 
corresponding disease specific biomolecules. A more physiologically relevant test 
condition can be set up for studying nano/micro drug carrier distribution and binding.  
The testing platform can be extended for studying particle drug delivery in organs 
like lungs where the microvasculature is under periodic deformation during the breathing 
process. Periodically stretching microfluidic platforms will help in studying if the strain 
caused by the stretching effect has any role to play in particle drug distribution. The 
introduction of pulsatile flow, blood flow pattern observed in vivo is also to be 
considered. Thereby the current microfluidic device can be engineered into a universal 
platform for examining nano/micro drug particle delivery in physiologically relevant 
conditions. 
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